Cost-effectiveness analysis of phenotypic-guided versus guidelines-guided bronchodilator therapy in viral bronchiolitis

Objectives Although recent evidence suggests that management of viral bronchiolitis requires something other than guidelines‐guided therapy, there is a lack of evidence supporting the economic benefits of phenotypic‐guided bronchodilator therapy for treating this disease. The aim of the present stud...

Full description

Autores:
Rodríguez-Martínez, Carlos E.
Niño, Gustavo
Castro-Rodriguez, Jose A.
Perez, Geovanny
Sossa‐Briceño, Mónica P.
Buendia, Jefferson Antonio
Tipo de recurso:
https://purl.org/coar/resource_type/c_6501
Fecha de publicación:
2020
Institución:
Universidad El Bosque
Repositorio:
Repositorio U. El Bosque
Idioma:
eng
OAI Identifier:
oai:repositorio.unbosque.edu.co:20.500.12495/5076
Acceso en línea:
https://hdl.handle.net/20.500.12495/5076
https://doi.org/10.1002/ppul.25114
Palabra clave:
Bronchiolitis
Clinical practice guidelines
Cost-effectiveness
Health economics
Phenotype
Rights
License
Acceso abierto